Chlornaphazine

Summary

Chlornaphazine (CHEMBL2107519) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 268.2 Da · C14H15Cl2N

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2107519
Name	Chlornaphazine
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	10307
Molecular formula	C14H15Cl2N
Molecular weight	268.2
InChIKey	XCDXSSFOJZZGQC-UHFFFAOYSA-N

SMILES: C1=CC=C2C=C(C=CC2=C1)N(CCCl)CCCl

IUPAC name: N,N-bis(2-chloroethyl)naphthalen-2-amine

Also known as: CB 1048, CB-1048, Chlornaphazine, Clornafazina, NSC-62209, R 48, R-48, CHLORNAPHAZINE

Patent coverage: 4,413 distinct patent families (16,757 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).